Sarah M Calkins, MD
Pathology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
Offices
5 locations · Peninsula Pathologists Medical Group Inc · 17 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Calkins’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A111787 · Current
Licensed to practise in California · since 2010 · expires 2028-04-30 · University of Toledo College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$73,675
Medicare paid this office $73,675 for 673 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 180 | $11,729 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 159 | $8,060 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 55 | $7,091 | $84 |
| Special stained specimen slides to examine tissue, each additional procedure | 45 | $4,905 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 40 | $3,809 | $73 |
See all 25 services
| Pathology examination of tissue using a microscope, intermediate complexity | 180 | $11,729 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 159 | $8,060 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 55 | $7,091 | $84 |
| Special stained specimen slides to examine tissue, each additional procedure | 45 | $4,905 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 40 | $3,809 | $73 |
| Pathology examination of tissue using a microscope, high complexity | 23 | $3,759 | $139 |
| Evaluation of fine needle aspirate with interpretation and report | 39 | $3,368 | $62 |
| Evaluation of fine needle aspirate with interpretation and report | 39 | $3,359 | $62 |
| Special stained specimen slides to examine tissue, each additional procedure | 39 | $3,125 | $25 |
| Special stained specimen slides to examine tissue, initial procedure | 52 | $2,451 | $37 |
| Special stained specimen slides to examine tissue, initial procedure | 54 | $1,798 | $31 |
| Evaluation of fine needle aspirate | 35 | $1,544 | $32 |
| Microscopic genetic analysis of tumor, manual | 19 | $1,537 | $37 |
| Cell examination of specimen, selective cellular enhancement technique | 53 | $1,462 | $24 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 22 | $1,401 | $19 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $1,378 | $57 |
| Microscopic genetic analysis of tumor, manual | 11 | $864 | $41 |
| Cell examination of specimen, selective cellular enhancement technique | 32 | $835 | $25 |
| Pathology examination of tissue using a microscope, moderately low complexity | 23 | $482 | $15 |
| Pathology examination of tissue using a microscope, moderately low complexity | 37 | $381 | $10 |
| Preparation of tissue for examination by removing any calcium present | 30 | $360 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 66 | $253 | $4 |
| Pathology clinical consultation for clinical problem, 5-20 minutes | 11 | $218 | $20 |
| Preparation of tissue for examination by removing any calcium present | 16 | $211 | $11 |
| Pathology examination of tissue using a microscope, limited examination | 22 | $85 | $4 |
Who their Medicare patients are
673 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 16% · Women 52% · Also on Medicaid 8% · Health risk score 1.32. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Cancer 33% · Diabetes 31% · Coronary heart disease 29% · Chronic kidney disease 28% · Atrial fibrillation 25% · Heart failure 20% · Depression 17% · COPD 14% · Dementia 8% · Stroke 7%.
The office billed $299,885, Medicare allowed $92,602 and paid $73,675; for 1,967 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 673 | 1,967 | 77 | 1.32 | $299,885 | $73,675 |
| 2023 | 589 | 1,461 | 75 | 1.28 | $273,625 | $52,243 |
| 2022 | 313 | 1,031 | 72 | 1.75 | $294,263 | $39,786 |
| 2021 | 275 | 1,022 | 71 | 1.69 | $320,637 | $43,782 |
| 2020 | 227 | 842 | 70 | 1.69 | $233,481 | $33,013 |
| 2019 | 268 | 811 | 68 | 1.55 | $245,870 | $33,579 |
| 2018 | 245 | 719 | 69 | 1.36 | $210,381 | $28,324 |
| 2017 | 313 | 873 | 69 | 1.59 | $265,070 | $37,796 |
| 2016 | 178 | 426 | 67 | 1.80 | $133,624 | $17,909 |
| 2015 | 202 | 549 | 67 | 1.76 | $236,266 | $19,426 |
| 2014 | 88 | 262 | 70 | 1.48 | $143,235 | $9,721 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 278 | $16,205 | $33 |
| Pathology examination of tissue using a microscope, moderately high complexity | 43 | $6,051 | $74 |
| Cell examination of specimen, selective cellular enhancement technique | 205 | $5,036 | $24 |
| Evaluation of fine needle aspirate with interpretation and report | 60 | $4,571 | $63 |
| Special stained specimen slides to examine tissue, each additional procedure | 44 | $4,149 | $26 |
| Special stained specimen slides to examine tissue, initial procedure | 71 | $2,522 | $32 |
| Pathology examination of tissue using a microscope, high complexity | 15 | $2,244 | $132 |
| Evaluation of fine needle aspirate | 56 | $2,161 | $32 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 12 | $1,927 | $161 |
| Microscopic genetic analysis of tumor, manual | 16 | $1,207 | $38 |
| Pathology examination of tissue using a microscope, moderately low complexity | 33 | $357 | $10 |
| Pathology examination of tissue using a microscope, limited examination | 45 | $176 | $4 |
2022: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 140 | $8,327 | $34 |
| Evaluation of fine needle aspirate with interpretation and report | 69 | $5,282 | $62 |
| Pathology examination of tissue using a microscope, moderately high complexity | 30 | $4,642 | $75 |
| Special stained specimen slides to examine tissue, each additional procedure | 41 | $3,680 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 113 | $2,830 | $25 |
| Evaluation of fine needle aspirate | 67 | $2,528 | $31 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 33 | $2,405 | $73 |
| Special stained specimen slides to examine tissue, initial procedure | 58 | $2,065 | $31 |
| Fine needle aspiration biopsy, first growth | 16 | $748 | $47 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 18 | $629 | $20 |
| Special stained specimen slides to identify organisms including interpretation and report | 16 | $570 | $24 |
| Cell examination of specimen, concentration technique | 17 | $405 | $20 |
2021: 13 services
| Pathology examination of tissue using a microscope, intermediate complexity | 150 | $11,287 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 46 | $8,798 | $77 |
| Evaluation of fine needle aspirate with interpretation and report | 58 | $4,087 | $64 |
| Pathology examination of specimen during surgery, first tissue block | 22 | $3,626 | $58 |
| Pathology examination of tissue using a microscope, high complexity | 14 | $2,570 | $135 |
| Evaluation of fine needle aspirate | 58 | $2,053 | $32 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 25 | $1,881 | $75 |
| Special stained specimen slides to examine tissue, initial procedure | 49 | $1,744 | $32 |
| Special stained specimen slides to examine tissue, each additional procedure | 25 | $1,732 | $26 |
| Cell examination of specimen, selective cellular enhancement technique | 68 | $1,084 | $15 |
| Fine needle aspiration biopsy, first growth | 21 | $933 | $44 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $584 | $22 |
| New patient visit (15+ min) | 11 | $488 | $44 |
2020: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 111 | $9,058 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 16 | $3,883 | $81 |
| Evaluation of fine needle aspirate with interpretation and report | 44 | $3,649 | $66 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $2,636 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 11 | $2,094 | $60 |
| Cell examination of specimen, selective cellular enhancement technique | 96 | $1,885 | $19 |
| Evaluation of fine needle aspirate | 41 | $1,721 | $34 |
| Pathology examination of tissue using a microscope, high complexity | 12 | $1,704 | $142 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 21 | $1,660 | $79 |
| Special stained specimen slides to examine tissue, initial procedure | 35 | $1,348 | $34 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $771 | $27 |
2019: 10 services
| Pathology examination of tissue using a microscope, intermediate complexity | 124 | $8,996 | $35 |
| Pathology examination of tissue using a microscope, moderately high complexity | 24 | $4,928 | $78 |
| Evaluation of fine needle aspirate with interpretation and report | 56 | $4,100 | $66 |
| Cell examination of specimen, selective cellular enhancement technique | 135 | $3,484 | $26 |
| Evaluation of fine needle aspirate | 47 | $1,785 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 39 | $1,580 | $34 |
| Special stained specimen slides to examine tissue, each additional procedure | 15 | $1,309 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 12 | $861 | $72 |
| Fine needle aspiration biopsy, first growth | 18 | $853 | $47 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 12 | $786 | $65 |
2018: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 107 | $5,678 | $35 |
| Evaluation of fine needle aspirate with interpretation and report | 63 | $4,634 | $66 |
| Pathology examination of tissue using a microscope, moderately high complexity | 14 | $3,635 | $79 |
| Cell examination of specimen, selective cellular enhancement technique | 116 | $3,047 | $26 |
| Special stained specimen slides to examine tissue, each additional procedure | 25 | $2,281 | $27 |
| Evaluation of fine needle aspirate | 59 | $2,091 | $32 |
| Special stained specimen slides to examine tissue, initial procedure | 37 | $1,371 | $33 |
| Fine needle aspiration biopsy, first growth | 19 | $1,222 | $58 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 11 | $859 | $78 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 14 | $569 | $21 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $402 | $25 |
2017: 14 services
| Pathology examination of tissue using a microscope, intermediate complexity | 118 | $6,866 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 38 | $5,855 | $78 |
| Evaluation of fine needle aspirate with interpretation and report | 72 | $5,644 | $66 |
| Evaluation of fine needle aspirate | 64 | $2,527 | $33 |
| Cell examination of specimen, selective cellular enhancement technique | 110 | $2,505 | $22 |
| Special stained specimen slides to examine tissue, each additional procedure | 26 | $1,945 | $27 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 24 | $1,896 | $79 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 13 | $1,894 | $146 |
| Special stained specimen slides to examine tissue, initial procedure | 39 | $1,565 | $33 |
| Fine needle aspiration biopsy, first growth | 19 | $1,239 | $59 |
| Fine needle aspiration using imaging guidance | 12 | $643 | $49 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $385 | $26 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 11 | $361 | $21 |
| Ultrasonic guidance for needle placement | 11 | $262 | $24 |
2016: 9 services
| Pathology examination of tissue using a microscope, intermediate complexity | 47 | $3,361 | $36 |
| Evaluation of fine needle aspirate with interpretation and report | 40 | $2,760 | $66 |
| Cell examination of specimen, selective cellular enhancement technique | 82 | $2,117 | $26 |
| Evaluation of fine needle aspirate | 31 | $1,105 | $33 |
| Fine needle aspiration biopsy, first growth | 15 | $897 | $60 |
| Special stained specimen slides to examine tissue, each additional procedure | 11 | $765 | $25 |
| Special stained specimen slides to examine tissue, initial procedure | 18 | $709 | $34 |
| Special stained specimen slides to identify organisms including interpretation and report | 12 | $359 | $26 |
| Cell examination of specimen, concentration technique | 12 | $301 | $21 |
2015: 7 services
| Evaluation of fine needle aspirate with interpretation and report | 66 | $4,824 | $62 |
| Pathology examination of tissue using a microscope, intermediate complexity | 58 | $3,534 | $34 |
| Cell examination of specimen, selective cellular enhancement technique | 113 | $2,770 | $24 |
| Evaluation of fine needle aspirate | 55 | $2,152 | $33 |
| Fine needle aspiration biopsy, first growth | 32 | $2,149 | $57 |
| Special stained specimen slides to examine tissue, initial procedure | 30 | $1,017 | $32 |
| Special stained specimen slides to examine tissue, each additional procedure | 13 | $1,002 | $19 |
2014: 6 services
| Evaluation of fine needle aspirate with interpretation and report | 38 | $3,207 | $62 |
| Evaluation of fine needle aspirate | 34 | $1,440 | $31 |
| Pathology examination of tissue using a microscope, intermediate complexity | 27 | $1,057 | $33 |
| Cell examination of specimen, selective cellular enhancement technique | 33 | $849 | $24 |
| Pap test | 11 | $305 | $28 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $165 | $10 |
Medicaid work
$527 in 2024
Medicaid paid $527 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 12 | $527 |
| 2024 | 12 | 1 | 12 | $527 |
| 2023 | 117 | 2 | 25 | $5,218 |
| 2022 | 75 | 2 | 20 | $4,065 |
| 2020 | 23 | 1 | 23 | $402 |
| 2019 | 34 | 2 | 15 | $1,747 |
| 2018 | 34 | 1 | 18 | $912 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 54 | $3,215 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 63 | $2,003 |
2022
| TISSUE EXAM BY PATHOLOGIST | 43 | $2,766 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 32 | $1,300 |
2020
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 23 | $402 |
2019
| TISSUE EXAM BY PATHOLOGIST | 19 | $1,236 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 15 | $510 |
2018
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 34 | $912 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2023 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | I-Stat | $25 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-06-04 | I-Stat | $25 |
See earlier years (2023)
2023: $20
| Genentech USA | None | $20 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1073848503
- Licence
- CA A111787California A111787: Current · expires 2028-04-30
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ZC0500X (207ZC0500X)
- Mailing address
- 505 Parnassus Ave, Room M-580, San Francisco, CA, 94143
- NPI first listed
- 2009-10-16
- NPI last updated
- 2018-05-24
This is when the NPI record was last certified, not a medical board exam.